Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Smurfit Kappa reports 'very strong' first quarter

(Sharecast News) - Smurfit Kappa Group reported robust first-quarter revenue of €2.7bn in an update on Thursday, alongside EBITDA of €487m, making for an EBITDA margin of 18.0%. The FTSE 100 company said that in line with expectations, it experienced continued growth in corrugated box volumes during the period.

It also successfully completed a bond offering totaling $2.75bn.

The board said the integration planning for the firm's merger with WestRock was meanwhile progressing smoothly.

"Smurfit Kappa Group has delivered a very strong first quarter," said group chief executive Tony Smurfit.

"These results reflect the continuing benefits of our multi-year capital plans and the dedication and commitment of our people, providing the most sustainable and innovative packaging solutions for our customers.

"Box demand has continued to improve with volume growth in Europe and the Americas of approximately 3% and 2% respectively."

Smurfit noted that the group recently announced the closure of a triple tranche bond offering, comprising $750m notes due 2030, $1bn due 2034 and $1bn due 2054, at coupons of 5.200%, 5.438% and 5.777% respectively.

"Our integration planning with WestRock is progressing well and as expected. We remain on-track to complete the transaction in early July.

"SKG has once again delivered.

"Due to our investment program in recent years and set against an improving industry backdrop with long-term positive structural trends, our combination with WestRock creates a global leader in innovative and sustainable packaging with a very exciting future for all stakeholders."

At 0806 BST, shares in Smurfit Kappa Group were up 3.51% at 3,596p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hikma boosts injectables business with Xellia assets acquisition
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.
Ascential on track to hit targets this year
(Sharecast News) - Publishing, events and B2B consultancy group Ascential has said that trading is in line with expectations for the full year, helped by strong growth in marketing and fintech operations.
AstraZeneca's Imfinzi gets US approval for endometrial cancer patients
(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.
British Land CFO to join Kingfisher
(Sharecast News) - B&Q owner Kingfisher said it had appointed British Land chief financial officer Bhavesh Mistry to the same role at the home improvement company.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.